苯巴那酯的购买渠道有哪些？

Phenobarnate is a drug used to treat specific types of epilepsy. It can significantly reduce the frequency of partial epileptic seizures in adults. It was developed by the Italian ANGELINI company and was approved by the US FDA in 2019. Since the drug is not yet available in China, patients need to purchase it through specific channels. This article will introduce in detail the purchasing channels, global availability and price information of Phenomenate to help patients and their families better understand how to obtain this drug.

What are the purchase channels for Phenobarate?

It is not currently available in China. Patients need to purchase it through other formal channels. The following are several possible purchase methods.

Cross-border medical service agencies

Professional cross-border medical service agencies cooperate with foreign pharmacies or hospitals to provide patients with legal drug purchase services. When choosing such an institution, you need to verify its qualifications and drug sources to avoid purchasing fake or substandard drugs.

Cross-border e-commerce platforms

Some cross-border e-commerce platforms provide overseas drug purchase services. Patients can place orders through these platforms, but they need to pay attention to whether the platform has drug sales qualifications and carefully check the production date and packaging information of the drugs.

Overseas direct mail

Patients can also send medicines directly from abroad through overseas relatives and friends or through formal channels. When receiving medicines, be sure to check the integrity of the medicines and retain proof of purchase for inspection.

No matter which method of purchasing, patients should be wary of the risks of counterfeit drugs and ensure the authenticity and reliability of the drugs.

Phenobarnate’s marketing status

Phenobarnate has been approved for marketing in some countries and regions, but has not yet been approved in China.

U.S. market

In November 2019, Phenobarnate was approved by the U.S. FDA for the treatment of specific types of epilepsy. Currently, the supply in the U.S. market is stable and patients can purchase it through formal channels.

European Market

Many European countries have also approved the marketing of Phenobarnate, especially Italian ANGELINI Company, as the main manufacturer, with a wide supply coverage.

Chinese market

Phenobarnate has not yet been launched in China, nor has it been included in the medical insurance catalog. If domestic patients need to purchase it, they need to obtain it through cross-border medical service institutions or cross-border e-commerce platforms.

Globally, the marketing status of phenobarnate varies greatly, and patients need to choose purchase channels based on the actual situation in their region.

The price of Phenobarnate

The price of Phenobarnate varies depending on specifications and manufacturers. The following is the price information of Phenobarnate produced by Italian ANGELINI Company.

Price comparison of different specifications

The price of 12.5mg+25mg*28 tablets is about US$206/box; the price of 50mg*84 tablets and 200mg*84 tablets is about US$521/box; the price of 50mg*28 tablets is about US$231/box; the price of 50mg*14 tablets is about US$117/box.

Price Influencing Factors

The price of Phenobarnate is affected by specifications, packaging quantity and market demand. Large-format packaging usually has a lower unit price, while small-format packaging is more suitable for short-term medication needs.

Patients can choose appropriate specifications according to their own medication needs. At the same time, they must pay attention to the authenticity and source reliability of the medicine.